(4-fluoro-3-methoxyphenyl)boronic acid
Product Information
Molecular Formula
C7H8BFO3
Molecular Weight
169.95
Description
(4-fluoro-3-methoxyphenyl)boronic acid is a pharmaceutical intermediate known for its role in the synthesis of many experimental drugs. It has been used to develop targeted cancer therapies and drugs for neurodegenerative diseases.
Synonyms
(4-fluoro-3-methoxyphenyl)boronic acid; 4-Fluoro-3-methoxybenzeneboronic acid; Boronic acid, (4-fluoro-3-methoxyphenyl)-; 4-fluoro-5-methoxyphenylboronic acid; 3-Methoxy-4-fluorophenylboronic acid; B-(4-Fluoro-3-methoxyphenyl)boronic acid; Boronic acid, B-(4-fluoro-3-methoxyphenyl)-; 3-Methoxy4-fluorophenylboronic acid; (4-fluoro-3-methoxyphenyl)boronicacid; 4-fluoro-3-methoxyphenyl boronic acid; (4-fluoro-3-methoxyphenyl)boronic acid
IUPAC Name
(4-fluoro-3-methoxyphenyl)boronic acid
SMILES
B(C1=CC(=C(C=C1)F)OC)(O)O
InChI
InChI=1S/C7H8BFO3/c1-12-7-4-5(8(10)11)2-3-6(7)9/h2-4,10-11H,1H3
InChI Key
LUJMSRVFSBMEOY-UHFFFAOYSA-N
Flash Point
Not applicable
Safety Information
Hazards
H302 - H319
Precautionary Statement
P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
2
Exact Mass
170.0550524 g/mol
Monoisotopic Mass
170.0550524 g/mol
Topological Polar Surface Area
49.7Ų
Heavy Atom Count
12
Formal Charge
0
Complexity
145
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113603708-A | Preparation method and application of novel CDK9 inhibitor with macrocyclic framework structure | 2021-07-27 |
| CN-112939923-A | Organic photochromic compound and preparation method and application thereof | 2021-01-18 |
| US-2022040336-A1 | Heterobiaryl compounds and imaging agents for imaging huntingtin protein | 2020-08-06 |
| WO-2022026892-A1 | Piperidin-1- yl-n-pyrydi ne-3-yl-2-oxoacet am ide derivatives useful for the treatment of mtap-deficient and/or mt a-accumulating cancers | 2020-07-31 |
| WO-2021203010-A1 | Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd) | 2020-04-03 |
| WO-2021203023-A1 | Indole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd) | 2020-04-03 |
| WO-2021203025-A1 | 1 h-pyrazolo[4,3-g]isoquinoline and 1 h-pyrazolo[4,3-g]quinoline derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd) | 2020-04-03 |
| WO-2021175270-A1 | Novel hpk1 inhibitor, preparation method therefor and application thereof | 2020-03-03 |
| US-2020361939-A1 | Modulators of alpha-1 antitrypsin | 2019-05-14 |
| WO-2020117961-A1 | Morpholinyl, piperazinyl, oxazepanyl and diazepanyl o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors | 2018-12-05 |
